Rex Fang & Innovation Equity Premium Income ETF vs Philip Morris International Inc. — how do they compare? Rex Fang & Innovation Equity Premium Income ETF trades at $43.53 (market cap $746.48M), while Philip Morris International Inc. trades at $200.2 (market cap $312.50B). The key difference: Philip Morris International Inc. is far larger — about 418.6× Rex Fang & Innovation Equity Premium Income ETF's market cap, and Philip Morris International Inc. pays a 3.19% dividend while Rex Fang & Innovation Equity Premium Income ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Rex Fang & Innovation Equity Premium Income ETF for 56 Days and Philip Morris International Inc. for 85 Days on average.
| FEPI | PM | |
|---|---|---|
Market Cap | $746.48M | $312.50B |
Volume | 334,337 | 5,517,172 |
Sector | Income / Options Overlay | Consumer Staples |
52-Week High | $49.54 | $200.50 |
52-Week Low | $37.98 | $144.33 |
Typical Hold Time | 56 Days | 85 Days |
Enterprise Value | — | $355.62B |
Dividend Yield | — | 3.19% |
Signals from Pluang's Aura AI — not financial advice
FEPI (REX FANG & Innovation Equity Premium Income ETF) trades at $43.59, showing minimal daily movement with a -0.17% decline. The ETF employs a covered call strategy on AI and mega-cap tech stocks, generating substantial weekly dividends averaging $0.20-0.21 per distribution. Technical indicators show a bullish trend with strong moving average support, though RSI levels suggest potential overbought conditions. Recent news highlights FEPI's 25% yield but questions its total return performance compared to peers.
FEPI offers high income generation through its covered call strategy but faces challenges in capital appreciation and drawdown protection. The concentrated tech exposure creates volatility risk, particularly if AI momentum slows. While the weekly dividend structure appeals to income investors, the capped upside and elevated risk profile warrant caution for total return seekers.
Philip Morris International (PM) trades at $200.5, up 5.3% over 24 hours, with a bullish technical signal and strong earnings beats in Q1 and Q2 2026. The company shows robust fundamentals with 2025 revenue of $40.65B and net income of $11.35B, supported by a 67.48% gross margin. Recent news highlights expansion of smoke-free products like ZYN and IQOS, now over 40% of revenue, driving growth amid industry shifts.
Outlook is positive with analyst consensus at Buy (68%) and a $212.17 price target, though elevated P/E of 26.46 and regulatory risks in tobacco remain concerns. Earnings growth and smoke-free product adoption are key catalysts, but investors should monitor debt levels and competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.
Read more on FEPI →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →